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ABSTRACT
In mammalian mitochondria, messenger RNA is processed and matured from large 
primary transcripts in structures known as RNA granules. The identity of the factors and 
process transferring the matured mRNA to the mitoribosome for translation is unclear. 
Nascent mature transcripts are believed to associate initially with the small mitoribosomal 
subunit prior to recruitment of the large subunit to form the translationally active 
monosome. When the small subunit fails to assemble, however, the stability of mt-mRNA 
is only marginally affected, and under these conditions the LRPPRC/SLIRP RNA binding 
complex has been implicated in maintaining mt-mRNA stability. Here, we exploit the 
activity of a bacterial ribotoxin, VapC20, to show that in the absence of the large 
mitoribosomal subunit, mt-mRNA species are selectively lost. Further, if the small subunit 
is also depleted, the mt-mRNA levels are recovered. As a consequence of these data, we 
suggest a natural pathway for loading processed mt-mRNA onto the mitoribosome.
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INTRODUCTION
The human mitochondrial genome is transcribed from single promoter regions on each of 
the two strands [1,2]. The resultant large polycistronic RNA units are processed into 
individual messenger (mt-mRNA), ribosomal (mt-rRNA) or transfer (mt-tRNA) RNAs and 
are subsequently matured. Many of these events are described as occuring in discrete 
RNA granules close to the mtDNA in the mitochondrial matrix [3]. The early stages of 
mitochondrial ribosome assembly also occur within or close to these granules [4]. Apart 
from synthesis and maturation, much of the life cycle of mt-mRNA is unclear [5]. Early in 
vitro studies support the notion that mt-mRNA is first loaded onto the mammalian 
mitoribosomal 28S small subunit (mt-SSU) [6,7] but how is the nascent mt-mRNA 
transported to the mt-SSU and how is it protected ? Is mt-mRNA protected by the mt-
SSU alone, or is stability dependent on further association with the mitoribosomal 39S 
large subunit (mt-LSU) and associated factors ? For example, the RNA-binding complex 
formed by LRPPRC/SLIRP has been implicated in stabilising mt-mRNA that is not bound 
to the mitoribosome [8] and exposing its required sites for translation [9]. A recent report 
suggests SLIRP promotes correct association of mt-mRNA with the mitoribosome [10]. 
Degradation of the antisense or mirror mt-mRNAs clearly involves the mitochondrial 
PNPase in tandem with the hSUV3 helicase [11], but are these proteins also involved in 
sense mt-mRNA degradation, and what promotes this degradation event ? 
In an attempt to address some of these questions, we set out to selectively 
remove the mt-LSU. To facilitate this, we have exploited the sequence specificity of 
mycobacterial endoribonuclease, VapC20 [12]. This PIN domain protein is part of the 
extensive toxin:antitoxin system that is found within Mycobacterium tuberculosis. It 
associates with the bacterial large ribosomal subunit and cleaves the 23S ribosomal RNA 
within the highly conserved sarcin:ricin loop (SRL), unless bound to its cognate VapB20 
antitoxin counterpart [12,13]. The exquisite cleavage selectivity is believed to be due to 
the ribonuclease recognising the environment of SRL within the context of the ribosome, 
as VapC20 will not cleave isolated ribosomal RNA, in vitro or in vivo [12]. The SRL is 
essential during the elongation step of protein synthesis allowing the formation of 
stabilizing contacts between the ternary complex EF-Tu/aa-tRNA/GTP and the ribosome 
[14]. Being close to their GTPase domains, this rRNA loop interacts with both EF-Tu and 
EF-G [15,16] and its cleavage differentially affects elongation factors binding to the A
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bacterial ribosome [17]. The interaction of LSU rRNA with GTPases has also been 
described recently in human mitochondria, where the 16S mt-rRNA domain VI, including 
the SRL and helices H96-H97, interacts with human MTG1, a conserved GTPase that 
couples mt-LSU assembly with intersubunit bridge formation [18].
Analysis revealed a strong but incomplete sequence identity between the SRL of 
E. coli 23S rRNA and the human mitochondrial 16S rRNA. By fusing the VapC20 protein 
downstream of a mitochondrial localisation signal, we have been able to show that, on 
induction, mtVapC20 localises specifically to the mitochondrial matrix where it cleaves 
uniquely the mitoribosomal 16S rRNA not in the SRL, but in helix 91 that is immediately 
adjacent to the SRL, in the folded 16S mt-rRNA. Expression of mtVapC20 caused the 
temporal and substantial depletion of the mt-LSU without a concomitant decrease of mt-
SSU, resulting in the loss of almost all mt-mRNA species tested. In many other systems 
that have been manipulated, levels of the LRPPRC/SLIRP complex reflect the steady 
state levels of most mt-mRNA species, consistent with a mutual interdependency for 
stability [10,19–21]. Under conditions of mtVapC20 expression, however, even with 
vanishingly low levels of mt-mRNA, the LRPPRC/SLIRP complex is maintained. Notably, 
when mt-SSU is depleted in tandem with mt-LSU, mt-mRNA levels as measured by the 
levels of MTCO1, are partially recovered.
We hypothesise that monosome formation is required to promote the natural 
stability of the mt-mRNA following its transfer from LRPPRC/SLIRP complex.
RESULTS
mtVapC20 localises to the human mitochondrial matrix.
To determine whether VapC20 could cleave mitochondrial 16S rRNA, a Flp-In™ 293 T-
REx cell line was engineered to inducibly express M. tuberculosis VapC20 fused in-frame 
with an N-terminal mitochondrial pre-sequence from the N. crassa ATP synthase subunit 
9 (Su9; [22]) as described. Clones were isolated and inducible mtVapC20 expression 
was confirmed. After 7 days of induction the cell media acidified, consistent with an 
OXPHOS deficiency; however, following 9 days induction cell growth was only mildly 
affected (Fig. 1A). To assess whether mitochondria-targeted VapC20 (mtVapC20) was 
successfully imported into the mitochondrial matrix, mitochondria were isolated from an 
induced clonal line and subfractionated. The mtVapC20 displayed clear colocalization A
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with markers of the mitochondrial matrix, glutamate dehydrogenase and mitochondrial 
elongation factor Tu (Fig. 1B). The product size (approx. 15 kDa, upper panel) was 
compatible with the cleavage of the Su9 presequence. Precursor was undetectable, 
consistent with a high level of import of the expressed product into mitochondria.
mtVapC20 selectively cleaves the 16S mt-rRNA.
Initial sequence and structure comparisons showed significant similarity between the E. 
coli 23S sarcin:ricin loop (SRL) and the mitochondrial 16S rRNA SRL (Fig. 2A), however, 
the region is not entirely conserved. To determine whether mtVapC20 was able to cleave 
the 16S mt-rRNA, total cell RNA was isolated following a time course of induction. 
Northern blot analysis with probes covering 5’ and 3’ sequences revealed a unique 
product of approximately 200 nucleotides, detected specifically with the 3’ probe after 24 
hours induction (Fig. 2B, C). Although specific cleavage occurred, the exact product size 
was unexpected, as cleavage in the SRL should generate a shorter 3’ product of 100 
nucleotides. Trapping of the digestion product by 5’ blocked ligation-mediated PCR and 
sequence analysis revealed a spectrum of products differing at their 5’ termini by a few 
bases but clearly indicating that cleavage occurred not at the SRL but at helix 91 (Fig. 
2B, lower panel), shown to be only several angstroms away from the SRL after folding of 
the 16S mt-rRNA (Fig. 2D, [23]). Interestingly, crystal structures of the bacterial ribosome 
show that helix 91 of the 23S rRNA establishes loop-loop tertiary interactions with SRL 
[24]. This tight conformation seems to be essential for both the assembly and the function 
of the large ribosomal subunit [25].
Assembly of the mt-SSU is independent of mt-LSU formation.
To determine the effect of 16S mt-rRNA cleavage, extracts were isolated at various 
stages post induction and subjected to western or northern blot analysis. The 
mitochondrially encoded complex IV protein, COX2, was depleted by day 3 of induction 
and was markedly affected after 7 days (Fig. 3A). Similarly, NDUFB8, a nuclear encoded 
protein but a sensitive marker of complex I assembly, was also significantly depleted. 
Metabolic labelling of mitochondrial gene products was also substantially affected after 2 A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved
days induction (Fig. 3B). These data are consistent with reduced mitochondrial protein 
synthesis. To determine the steady state levels of the mitochondrial ribosome, markers of 
the large (mt-LSU) and small (mt-SSU) subunit were assessed (Fig. 3A). Steady state 
levels of mt-LSU components uL3m, uL11m and mL45 were depleted after 3 days but 
were markedly affected after 7 days, consistent with cleavage of the 16S mt-rRNA 
leading to loss of mt-LSU assembly. In contradistinction, mt-SSU components mS29 and 
mS22 were unaffected, suggesting that mt-SSU can assemble and remain stable in the 
absence of mt-LSU. Targeting of the nuclease-deficient D5A-mtVapC20 mutant had no 
measurable effect on the levels of OXPHOS components or mitoribosome (Fig. 3C). To 
confirm that mt-SSU assembly was unaffected, mtVapC20 was expressed for varying 
time periods and extracts were subjected to isokinetic sucrose gradient analysis. After 3 
days induction, fully assembled mt-LSU was almost undetectable (Fig. 4A, fractions 6/7) 
with unassembled subunits being rapidly degraded or unexpressed. The mt-SSU, 
however, is retained (compare signals for mS29 in fractions 4/5 of uninduced and 6 days 
mtVapC20 induction). To further confirm the specific loss of mt-LSU on mtVapC20 
induction, RNA-FISH was performed with probes specific to either the 16S or 12S mt-
rRNA (Fig. 4B, C). After 6 days induction, mtVapC20 led to a marked decrease in signal 
for 16S mt-rRNA alone, consistent with the specific loss of mt-LSU.
Absence of mt-LSU negatively affects mt-mRNA levels.
Previous data has shown that the depletion of mt-SSU induced by a lack of modification 
or stability of the 12S mt-rRNA in both mice models and in human cell lines does not 
promote increased degradation of most mt-mRNAs [26,27]. To assess whether mt-mRNA 
is similarly protected when the mt-LSU is absent, mtVapC20 was expressed for varying 
periods, after which RNA was isolated and northern blots performed (Fig. 5). Levels of 
analysed mt-tRNAs were unaffected or only slightly reduced (Fig. 5A), consistent with the 
lack of any appreciable effect on mtDNA content (with exception for 10 days expression 
where mtDNA levels were increased) or transcription (Fig. 6). Further, 12S mt-rRNA 
levels were only minimally depleted (Fig. 5B), reflecting the specificity of mtVapC20 
cleavage and that mt-SSU assembly was unaffected. Noticeably, however, although the 
pattern of steady state levels over the induction time course varied between mt-RNA 
species, all mt-mRNA species analysed showed decreases in steady state level by day A
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10. The assessed mt-mRNA levels quantitatively reflected the decreasing levels shown 
for 16S mt-rRNA, the marker of assembled mt-LSU. MTND3 was only mildly affected 
(Fig. 5A), even after 10 days induction (approx. 40% of control). Thus, in the absence of 
mt-LSU the majority of mt-mRNA species appear to be selectively lost. 
With the aim of analysing the association of mt-mRNA with mitoribosomes, mtVapC20 
was expressed for 3 or 6 days, extracts subjected to isokinetic sucrose gradient 
separation, followed by isolation of RNA from each fraction. Northern blot analysis (Fig. 
5C) confirmed the presence of 12S mt-rRNA that was normally associated with 
assembled mt-SSU (fractions 4/5), even after 6 days of toxin expression. The 16S mt-
rRNA and mt-mRNA species were strongly depleted and mainly associated with the 
remaining fraction of fully assembled monosome (6 days, fractions 8/9). The only 
exception was MTND3 that showed a lower rate of decrease and a different distribution 
within the gradient after 3 days of induction, accumulating in the lighter fractions.
LRPPRC/SLIRP is unaffected by the loss of mt-LSU. 
Evidence from patients, various transgenic mouse and human cultured cell models have 
implicated the LRPPRC/SLIRP RNA-binding complex in the stability of mt-mRNA [10,19–
21]. A substantial pool of data now shows a correlation between steady state levels of mt-
mRNA species and levels of LRPPRC. Increased steady state transcript levels have 
been shown to mirror increased LRPPRC levels as observed in mouse models depleted 
for the 12S mt-rRNA methylase NSUN4 [28]. Several research groups have also reported 
that LRPPRC depletion led to decreased stability of most mt-mRNA species in both 
cellular and animal models [8,20,29,30]. Thus, upon mtVapC20 induction, LRPPRC 
levels would be predicted to decrease, to reflect the mitochondrial transcript reduction. 
Western blotting of extracts was performed following induction and showed that there 
was no measurable effect on the steady state levels of LRPPRC or SLIRP (Fig. 7A).
Recovery of steady state levels of mt-mRNA upon tandem depletion of mt-LSU and 
mt-SSU.A
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One viable possibility to reconcile this large body of data with our observation is that in 
the absence of mt-LSU, as facilitated by expression of mtVapC20, all mt-SSU may be 
freely available and capable to receive mature mt-mRNA from the LRPPRC/SLIRP 
complex but on transfer, there is no mt-LSU to form the monosome, resulting in loss of 
protection for the mt-mRNA leading to its rapid degradation. One prediction of this 
hypothesis is that concomitant loss of mt-SSU and mt-LSU should lead to restoration of 
transcript stability as the newly mature transcript would remain associated with the 
LRPPRC/SLIRP complex. To test this prediction, mt-SSU levels were partially reduced by 
depleting the 12S mt-rRNA chaperone, ERAL1. This was achieved by specific siRNA 
downregulation prior to the induction of mtVapC20. As shown in Fig. 7B, ERAL1 is 
depleted, resulting in less mt-SSU as evidenced by the reduction in 12S mt-rRNA (Fig. 
7C, lane 3). Concomitantly, induction of mtVapC20 lowered the mt-LSU levels, evidenced 
by 16S mt-rRNA reduction (Fig. 7C, lanes 2-4). Although the reduction in mt-SSU is only 
partial, there is a recovery in the steady state levels of MTCO1 transcript (Fig. 7C, lane 
3).
DISCUSSION
Targeting of the selective bacterial endoribonuclease VapC20 to human mitochondria 
results in the cleavage of 16S mt-rRNA with the resultant loss of mt-LSU. Unexpectedly, 
although the toxin has been shown previously to cleave E. coli 23S rRNA in exactly the 
same position in helix 95 as sarcin and other eukaryotic ribotoxins, mtVapC20 does not 
cleave the SRL of 16S mt-rRNA in helix 95 but at helix 91, which is in close apposition to 
the SRL in the mitoribosome. In vitro, VapC20 is unable to cleave purified 23S rRNA 
alone, suggesting that cleavage requires a particular environment provided by the 
assembled or assembling ribosome. It would appear that in the case of the 16S mt-rRNA, 
the SRL is recognised but actual cleavage occurs close to this site within the RNA. By 
targeting VapC20 to human mitochondria, we have shown that the mt-SSU can assemble 
in the absence of the mt-LSU. The work also suggests that the natural stability of mt-
mRNA shows dependence on the mt-LSU, presumably due to it combining with the mt-
SSU to form the monosome, thus protecting the bound transcript.
Several previous reports have detailed the molecular consequences when mt-LSU 
assembly has been partially compromised. Intriguingly, in certain cases where levels of A
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mt-mRNA were assessed, there was no evidence that mt-mRNA stability was reduced. 
Two recent publications report the effect of depletion of the DDX28 helicase [4,31], which 
partially affects mt-LSU biogenesis. The maximal depletion of 16S mt-rRNA, as a 
surrogate marker of assembled mt-LSU, in each report did not fall below 40% levels of 
control. In contrast, longer term shRNA-mediated depletion of the mt-LSU component 
mL44 led to mitochondrial 16S rRNA levels dropping below 10% of control levels with a 
concomitant reduction of most mt-mRNA [32], similar to our current report. One 
explanation for this apparent discrepancy is that depletion of DDX28 may cause aberrant 
mt-LSU assembly, whereby monosome formation is still possible but translation is 
affected. This would also infer that levels of mt-LSU were present in substantial excess 
over mt-mRNA. Notably, our data showed that MTND3 mRNA behaved in a different 
way. Even after prolonged mt-LSU depletion (10 days induction), this transcript was still 
present. In SLIRP KO mice, MTND3 was the most affected transcript with respect to 
interactions with mitoribosomes [10]. Here, we report that in the absence of mt-LSU, but 
in the presence of SLIRP, MTND3 accumulated in the least dense fractions of the 
gradient, as did 12S mt-rRNA (Fig. 5C). These observations may reflect the fact that 
MTND3 is the shortest mt-mRNA. It could be more easily protected by the mt-SSU than 
longer transcripts by the LRPPRC/SLIRP complex as would be the case in mtVapC20 
cells.
There is mounting evidence that RNA maturation occurs within transient liquid droplets 
termed RNA granules and that this is likely to be where mitoribosomes are assembled 
[3,4]. Many of the components required for processing and maturation of mammalian mt-
mRNA are now known and many have been localised to these sub-mitochondrial 
compartments [33]. However, although numerous mitoribosomal subunits have also been 
found close to the nucleoid, it is still unclear how the mature mt-mRNA is loaded onto the 
mitoribosome or indeed where this occurs. Early in vitro studies supported the idea that 
mt-mRNA is first loaded onto the mt-SSU before monosome formation [6,7]. It has been 
also speculated that the monosome can form without mt-mRNA loaded onto it and that 
the mRNA is inserted later as with leaderless bacterial mRNAs [34,35]. This hypothesis 
implies that LRPPRC/SLIRP may load the mt-mRNA directly onto the monosome, not 
onto the mt-SSU. We believe our data is now consistent with a model whereby 
LRPPRC/SLIRP associates with newly processed mt-mRNAs, ensures normal A
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maturation through regulated polyadenylation also ensuring normal translation by 
transferring the mature mt-mRNA to the mt-SSU or to the monosome (Fig. 8). 
It has previously been shown that POLRMT knockout causes decrease of de novo 
mitochondrial transcription with a concomitant reduction of LRPPRC levels [21]. Although 
our data do not completely rule out a negative effect of mt-LSU lack on mitochondrial 
transcription, the unchanged levels of LRPPRC in VapC20 cells suggests that the 
selective loss of mt-mRNAs depends on their degradation rather than their diminished 
synthesis as a result of mt-LSU depletion. Hence, correct stability and translation are 
driven by monosome formation with the mt-LSU (Fig. 8). In the absence of 
LRPPRC/SLIRP, mt-mRNA can be degraded before associating with mitoribosomal 
subunits, with the remainder being aberrantly polyadenylated or aberrantly loaded onto 
the mitoribosome, resulting in translational abnormalities.
Finally, the inducible VapC20 cell line reported here could provide a tool for studying 
processes related to mitochondrial gene expression in humans. It may have potential to 
clarify some central aspects of mt-mRNA turnover and the identification of RNases 
involved in quality control of untranslated transcripts.
MATERIALS and METHODS
Tissue culture, contructs and transfections
293 Flp-In T-REx cells (Thermo Fisher Scientific, Carlsbad, CA, USA) were cultured 
(37˚C, humidified 5% CO2) in Dulbecco’s modified Eagle’s medium supplemented with 
10% (v/v) foetal calf serum, 50 µg/ml uridine, 1x non-essential amino acids and 10 µg/ml 
BlasticidinS. Stable transfections were carried out using the constructs described below 
and Superfect (Qiagen, Hilden, Germany) following manufacturer’s recommendations. 
Post transfection selection was performed with 100 µg/ml HygromycinB.
The construct to facilitate inducible expression of full length C-terminal 6xHis-tagged 
VapC20 (UniProtKB ID: P95004) was prepared by generating an amplicon using the 
plasmid pKW332549c [12] as a template and the following primers: For 5’-
CACACAGCGCGCCTACTCTTCCATGATCTTCGTCGACACGTC-3’ and Rev 5’-
ATTGCGGCCGCCTAATGGTGATGGTGATGGT-3’. The amplicon was BssHII/Not1 A
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digested and ligated into pcDNA5/FRT/TO plasmid carrying the N. crassa ATP synthase 
subunit 9 presequence, generating a Su9-VapC20-His fusion protein (mtVapC20) that 
was internalized into the mitochondrial matrix.
The non-toxic D5A-mtVapC20 construct was obtained by site-directed mutagenesis, 
performed with the QuikChange II Site-Directed Mutagenesis Kit (Stratagene, San Diego, 
CA, USA), following manufacturer’s guidelines. This mutant construct was generated with 
the following primers: D5A-sense 5’-TCCATGATCTTCGTCGCGACGTCCTTCTGGGCT-
3’, D5A-antisense 5’-AGCCCAGAAGGACGTCGCGACGAAGATCATGGA-3’, and 
pcDNA5/FRT/TO/Su9-VapC20-His as the template. Both the wild-type and mutated 
constructs were validated by sequencing of both DNA strands.
ERAL1 siRNA transfections were performed as described in [26] on approximately 
12,000 mtVapC20 inducible cells per cm2 with Lipofectamine RNAiMAX transfection 
reagent (Thermo Fisher Scientific) in Optimem-I medium (33 nM siRNA). Custom and 
control non-targetting (NT) duplex siRNAs were purchased pre-annealed from 
Eurogentec (Liege, Belgium):- ERAL1sense 5’-GUGUCCUGGUCAUGAACAAdTdT-3’; 
ERAL1antisense 5’- UUGUUCAUGACCAGGACACdTdT-3’).
For the growth curve analyses, 293 cells that could inducibly express mtVapC20 were 
seeded onto 6-well plates, induced with 1 µg/ml tetracycline or uninduced as controls, 
and propagated with the IncuCyte ZOOM® System (Essen BioScience, Ann Arbor, MI, 
USA). Sixteen fields per well, with biological triplicates were imaged every 3 hours for 9 
days. All images were analyzed by the IncuCyte ZOOM Software.
Cellular and mitochondrial subfractionation
Subcellular fractions were prepared as described previously [36] with few modifications. 
Cells expressing mtVapC20 were harvested, resuspended in HB (0.6 M mannitol, 10 mM 
Tris-HCl, pH 7.4, 1 mM EGTA), supplemented with 0.1% BSA (w/v), and subjected to 
standard differential centrifugation. Mitochondria were finally pelleted (11,000 g, 10 mins, 
4°C) and resuspended in HB. The post-mitochondrial supernatant (cytosolic fraction) was 
retained after centrifugation. To obtain sub-mitochondrial fractions, mitochondria (300 µg) 
were treated with proteinase K (PK, 1.5 µg) on ice for 30 mins followed by addition of 5 
mM PMSF, pelleted (11,000g, 10 mins, 4°C) and resuspended in HB. Mitoplasts were 
obtained resuspending PK-treated mitochondria in 9 volumes of 10 mM Tris-HCl, pH 7.4, A
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and treated with PK as described above. Proteins (40 µg) from whole cell lysate, 
cytosolic and mitochondrial fractions were separated by 12% SDS-PAGE, transferred to 
PVDF membrane and analysed by immunoblotting.
Northern blotting analyses
Northern blots were performed as described previously [37]. Briefly, cells expressing 
mtVapC20 were harvested at different time points (3, 7 and 10 days) and total RNA was 
extracted. Aliquots (10 µg) were electrophoresed through 1.2% agarose under denaturing 
conditions and transferred to GeneScreen Plus membrane (Perkin Elmer, Waltham, MA, 
USA) following the manufacturer’s protocol. Radiolabelled probes were generated using 
random hexamers on PCR-generated templates corresponding to internal regions of the 
relevant genes.
High resolution northerns were carried out to analyse the 16S mt-rRNA cleavage product 
and mt-tRNAs. Total RNA (2 µg) was denatured in 40% formamide/5 mM EDTA at 95˚C, 
5 mins before being separated through 15% urea polyacrylamide gels in 1x TBE (100 
mM Tris base, 100 mM boric acid, 2 mM EDTA disodium salt). RNA was transferred to 
GeneScreen Plus membrane in 0.25x TBE at 150 mA, 15 mins followed by 500 mA for 
30 mins after which the membrane was exposed to UV (optimal crosslink, Stratalinker, 
Stratagene). Hybridisation conditions and probes were as described in [38]. Signals were 
detected by Typhoon FLA 9500 phosphorimager (GE Healthcare Life Sciences, 
Marlborough, MA, USA) and quantified by ImageQuant TL 8.1 software (GE Healthcare 
Life Sciences). To detect the RNA fragment produced by mtVapC20 cleavage, the 
following primers were used that were specific to the 3’-end of 16S mt-rRNA:- SRLdown-
For 5’-TAAGGCCTACTTCACAAAGCG-3’; SRLdown-Rev 5’-
CTTGGGTGGGTGTGGGTATAA-3’.
The analysis to discriminate the mitochondrial 16S rRNA cleavage product was carried 
out by high resolution northern as described above with few modifications. Briefly, 
uninduced and mtVapC20-expressing cells were harvested at different time points, total 
RNA was extracted and 2 µg electrophoresed through a 4.5% urea polyacrylamide gel in 
1x TBE. For the detection of 16S mt-rRNA, two different probes were used, generated 
with the following primer pairs:- SRLdown-For and SRLdown-Rev (probe #1); 16S-For 5’-A
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CCAATTAAGAAAGCGTTCAAG-3’ and 16S-Rev 5’-CATGCCTGTGTTGGGTTGACA-3’ 
(probe #2, upstream of expected cleavage site).
5’-end ligation mediated RT-PCR
Total RNA (10 µg) was phosphorylated by T4 PNK (New England Biolabs, Ipswich, MA, 
USA) in the presence of 1 mM ATP to ensure ligatable ends post mtVapC20 cleavage. 
Phosphorylated RNAs of sizes between 150 and 300 nucleotides were fractionated and 
gel-purified on a 10% PAA/8M urea gel. Eluted RNA fragments were ligated with 20 pmol 
of RNA linker (L5, 5’OH-AGGGAGGACGAUGCGG-3’OH) in the recommended buffer by 
20 Units T4 RNA Ligase (New England Biolabs) at 37°C for 3 hours. The reaction was 
subjected to phenol/chloroform extraction and sodium acetate/ethanol precipitation. The 
product was reverse transcribed using the Superscript II enzyme (Thermo Fisher 
Scientific) primed with 10 pmol of SRLdown-Rev oligonucleotide.
An aliquot (10%) of this cDNA was used to programme a standard PCR reaction [0.5 mM 
dNTPs, 2 mM MgCl2, 3 Units Taq Polymerase (Thermo Fisher Scientific)], with 10 pmol 
of P5-For (5’-AGGGAGGACGATGCGG-3’) and 10 pmol of SRLdown-Rev. A PCR single 
product (~ 200 nt) was purified using E.Z.N.A. gel extraction kit (Omega Bio-Tek, 
Norcross, GA, USA) prior to DNA sequencing using BigDye terminator cycle sequencing 
chemistry (Applied Biosystems, Foster City, CA, USA) on the ABI PRISM 3130xl Genetic 
Analyzer (Thermo Fisher Scientific). Cycle sequencing reactions were carried out using 
20 ng of purified fragment as template primed with 10 pmol of the internal oligonucleotide 
INT-SRLdown-Rev (5’-GAAGGCGCTTTGTGAAGTAGG-3’).
Immunoblotting
Western blots were performed and developed as described in [39] using antibodies as 
follows :- 6XHis, VDAC, uL3m, mS29, SLIRP, COX2, NDUFA9, NDUFB8 (Abcam, 
Cambridge, UK); AIF, uL11m (New England Biolabs); eIF4E (Cell Signaling Technology, 
Danvers, MA, USA); SDHA (Thermo Fisher Scientific); mL45, mS40, mS22 (ProteinTech 
Group, Rosemont, IL, USA); LRPPRC (Santa Cruz Biotechnology, Dallas, TX, USA); -
actin (Sigma-Aldrich, St. Louis, MO, USA); GDH, EFTu (custom made).
De novo mitochondrial protein synthesisA
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Metabolic labelling of de novo mitochondrial protein synthesis in cultured cells was 
performed after 2 and 6 days of mtVapC20 induction and carried out as described by [40] 
incubating cells with [35S] methionine/cysteine (Perkin Elmer) for 1 hour. Aliquots (50 µg) 
of total cell protein were separated by 15% SDS-PAGE and radioactive signals were 
detected as described above.
Isokinetic sucrose gradient analysis
Cell lysates [1 mg in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 
1% Triton X-100, protease inhibitor cocktail, 1 mM PMSF and 10 mM MgCl2)] were 
prepared at different time points of mtVapC20 induction and loaded onto a linear sucrose 
gradient [1 ml, 10-30 % (v/v)] in 50 mM Tris-HCl, pH 7.2, 10 mM MgOAc, 40 mM NH4Cl, 
100 mM KCl, 1 mM PMSF and 50 μg/ml chloramphenicol. Gradients were subjected to 
centrifugation in a OptimaTLX bench ultracentrifuge (Beckman Coulter, Brea, CA, USA), 
using a TLS55 rotor at 39,000 rpm for 135 mins at 4°C. Eleven fractions (100 μl) were 
collected and analysed by immunoblot.
Southern blotting and qPCR analysis
Southern blotting was performed as previously described [36]. The MTCO2 probe was 
generated by PCR using the following primers:- COX2-For 5’-CCTAGAACCAGGCGAC-
3’ and COX2-Rev 5’-GTCGTGTAGCGGTGAA-3’, spanning residues 7966 to 8150 of the 
mtDNA reference sequence (GenBank ID: NC_012920.1). Radioactive signals were 
detected using a Typhoon FLA 9500 PhosphorImager (GE Healthcare Life Sciences).
To detect levels of mtDNA by quantitative PCR, the following primer pairs were used to 
amplify a sequence within each target gene:- ND1-For 5’-AATCGCAATGGCATTCC-3’ 
and ND1-Rev 5’-CGATGGTGAGAGCTAAGG-3’, ND4-For 5’-
CCATTCTCCTCCTATCCCTCAAC-3’ and ND4-Rev 5’-
CACAATCTGATGTTTTGGTTAAACTATATTT-3’. Cytosolic 18S rRNA was used as a 
reference: 18S-For 5’- GTAACCCGTTGAACCCCATT and 18S-Rev 5’- 
CCATCCAATCGGTAGTAGCG.
In organello RNA synthesisA
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The transcription assay was performed on mitochondria isolated from uninduced and 
mtVapC20-expressing cells (6 day induction) as previously described [41] with few 
modifications. Briefly, mitochondria (320 µg) were incubated with 10 µCi of [-32P]UTP 
(800 Ci/mmol, Perkin Elmer) for 1 hour at 37°C with gentle rotation. Mitochondria were 
then washed twice in washing buffer (10 mM Tris-HCl, pH 6.8, 0.15 mM MgCl2 and 10% 
glycerol) and pelleted by centrifugation at 12,000 g for 3 mins at 4°C. Pellets were 
resuspended in 1 ml of TRIzol® Reagent (Thermo Fisher Scientific) and RNA was 
extracted.
To analyse the products of the in organello transcription, RNA was fractionated on a 2.2 
M formaldehyde/1.4% agarose gel and stained by SYBRTM Gold (Thermo Fisher 
Scientific) to validate loading. The gel was dried and exposed to a PhosphorImager 
screen, and radioactive signals were detected as described above.
Mitochondrial rRNA FISH
Cells capable of inducibly expressing mtVapC20 were seeded onto coverslips in a 6-well 
plate, induced with 1 µg/ml tetracycline or left uninduced as controls. At 20-30% 
confluency, cells were fixed using 4% PFA/0.2% glutaraldehyde (10 mins, room 
temperature) and washed twice in 1x PBS. Cells were then permeablized (70% ethanol, 
1 hour, room temperature), washed twice with 1x PBS and equilibrated in 1 ml of wash 
buffer (10% formamide, 2x SSC) for 5 mins. 16S- and 12S mt-rRNA Stellaris® Probe 
Sets (Biosearch Technologies, Novato, CA, USA) were diluted in TE Buffer (10 mM Tris-
HCl, 1 mM EDTA pH 7.5) to 12.5 µM, then added 1:100 to hybridization buffer (10% 
formamide, 10% dextran sulphate, 2x SSC). Droplets (100 µl) of probe-hybridization 
buffer solution were placed onto parafilm in a humidified chamber on to which coverslips 
were lowered and incubated overnight at 37°C in a humidified atmosphere. Coverslips 
were rinsed, incubated twice in wash buffer (30 mins), then stored in 1x PBS until 
mounted in ProLong® Diamond Antifade Mountant. Confocal imaging was performed 
using a SP8 microscope (Leica, Wetzlar, Germany) fitted with a Leica HyD hybrid 
detector and Image J software was used to quantify fluorescence intensity. Each channel 
was analysed independently from maximum intensity projections generated from 
acquired stacks. To reduce background interference during intensity calculations, an area 
was segmented around the high intensity signal using thresholding. In all cases the area A
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was determined by thresholding the 12S mt-rRNA image. Image J was then used to 
measure the mean intensity for both channels using this area. The measurements were 
analysed using GraphPad Prism8 software.
FIGURE LEGENDS
Figure 1 – mtVapC20 expression and submitochondrial localisation. (A) Growth was 
monitored for 9 days of both uninduced and induced mtVapC20 293 cells (n=3) using the 
IncuCyte ZOOM® System. Error bars represent the standard deviation of independent 
measures (n=16) carried out every 3 hours on each well. Black vertical bars denote the 
replacement of cell media to prevent acidification. (B) Submitochondrial localisation of 
mt-VapC20 was determined by immunoblotting of fractions as described. Anti-6XHis 
antibody was used to detect mtVapC20 and the following markers for each mitochondrial 
compartment: Apoptosis-inducing factor (AIF: mitochondrial intermembrane space), 
glutamate dehydrogenase and mitochondrial elongation factor Tu (GDH and EFTu: 
mitochondrial matrix), and eukaryotic initiation factor 4E (eIF4E: cytosol). Data are 
representative of one experiment. MWM: molecular weight markers.
Figure 2 – The Sarcin Ricin Loop and its cleavage by mtVapC20 in human 
mitochondrial 16S rRNA. 
(A) Sequences of the human mitochondrial 16S rRNA SRL (GenBank ID: NC_012920.1, 
3115-3141) and bacterial 23S rRNA SRL (GenBank ID: NR_076322.1, 2648-2674) were 
aligned using the EMBL-EBI MView online tool (https://www.ebi.ac.uk/Tools/msa/mview/). 
Identical nucleotides are blocked in black. Structural superimposition of mitochondrial 
(red) and bacterial (amber) SRL RNA tertiary structures was performed with the web 
server MultiSETTER [42] uploading PDB files (human 16S mt-rRNA, PDB ID: 3J7Y; E. 
coli 23S SRL, PDB ID: 1Q9A) as input (S-distance 0.209, p-value 0.039). (B) Cleavage 
products generated following mtVapC20 expression were analysed by high resolution 
northern blot as described. Blots were hybridized with radiolabelled probes specific to A
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16S mt-rRNA 3’ end. Upper left panel: mtVapC20 cleavage product is indicated with an 
arrow. Upper right panel: RNA was stained by SYBRTM Gold (Thermo Fisher Scientific) to 
validate loading. Low Range ssRNA Ladder (New England Biolabs) sizes are indicated 
on the right. Lower panel: sequence analysis of 5’-end ligation mediated RT-PCR 
product. Blue bar depicts the sequence of 16S mt-rRNA helix 91. Data are representative 
of two independent experiments. (C) Cleavage analysis of 16S mt-rRNA was performed 
with two different probes. Total RNA was extracted from uninduced (U) and mtVapC20 
cells induced for 5 hours, overnight (O.N.) and 3 days. The mtVapC20 cleavage product, 
only detected using probe #1, is indicated with an arrow. Data for each time point are 
representative of two independent experiments. 5S rRNA was used as loading control. 
(D) Magnification of the boxed area shows the mtVapC20 cleavage site and its proximity 
to the SRL. Structures of the assembled human mitoribosome (PDB ID: 3J9M; mt-LSU in 
dark green, mt-SSU in light green) and the cleavage site were obtained with PyMOL 
software (Open Source, Version 1.8.2.0).
Figure 3 – Effects of mtVapC20 expression on mitochondrial translation.
(A) Cell lysates were prepared and aliquots (40 µg) subjected to immunoblotting as 
described. Steady state levels of representative OXPHOS subunits (green) were 
determined with antibodies against Complex I (NDUFA9 and NDUFB8) and Complex IV 
(COX2). Steady state levels of mt-LSU (blue) and mt-SSU (red) components were 
determined by western blot using antibodies against components of the mt-LSU [HUGO 
protein names: MRPL3 (uL3m); MRPL11 (uL11m); MRPL45 (mL45)] and mt-SSU [HUGO 
protein names: DAP3 (mS29); MRPS18B (mS40); MRPS22 (mS22)]  as indicated. 
Asterisk indicates that the antibody possibly recognises one of the two other mS40 
isoforms, mL66 (MRPS18A), found in the mt-LSU. Expression of mtVapC20 was 
detected by anti-6XHis antibody. β-actin and VDAC, a mitochondrial outer membrane 
protein, were used as loading control and mitochondrial marker, respectively. Data for 
each time point are representative of one experiment. (B) Metabolic 35S-met/cys labelling 
of mitochondrial translation products was performed in uninduced (U) and mtVapC20 
cells induced for 2 and 6 days as described. Mitochondrially-encoded polypeptides were 
assigned after Chomyn [43]. Data for each time point are representative of one 
experiment. Equivalent protein loading was confirmed by Coomassie blue staining (CBS). A
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(C) Immunoblotting analysis showing the effect of mutant mtVapC20 (D5A) expression on 
steady-state levels of OXPHOS Complex IV, subunit 2 (COX2) and a constituent of the 
large mitoribosomal subunit (uL3m). Mutant mtVapC20 was detected with the anti-6XHis 
antibody. VDAC was used as loading control. Data for each time point are representative 
of one experiment.
Figure 4 – Effects of mtVapC20 expression on mitoribosomal components.
(A) Isokinetic sucrose gradient centrifugation was used to analyse mitochondrial 
ribosomal protein distribution in mtVapC20 cells uninduced and induced for time periods 
as indicated. The migration of mt-SSU (red box) and mt-LSU (blue box) was determined 
using antibodies against mS29 (mt-SSU), uL3m and uL11m (mt-LSU). HUGO protein 
names: DAP3 (mS29); MRPL3 (uL3m); MRPL11 (uL11m). Data are representative of two 
independent experiments. (B) Changes to distribution of 16S mt-rRNA (in blue) and 12S 
mt-rRNA (in red) in uninduced and mtVapC20-expressing cells was determined by RNA 
FISH as described. For each sample, four representative confocal images are shown 
(scale bar: 10 µm). (C) Quantitative analysis of fluorescence intensities was performed 
using ImageJ and GraphPad Prism8 as detailed in Methods. Results are presented as 
the mean ± S.D. (n=9). Statistical analysis was performed using the Welch's T test (*, 
p<0.05; ****, p<0.0001).
Figure 5 – Effect of mtVapC20 expression on mitochondrially encoded RNAs. 
Steady state levels of mt-RNAs were assessed by high resolution (A) and standard (B) 
northern blot as described. Total RNA was extracted from uninduced (U) and mtVapC20 
cells induced (Ind) for 3, 7 and 10 days prior to analysis of RNA (2 µg per lane, A; 10 µg, 
B). Probes to cytosolic 5S rRNA and 28S rRNA were used as loading controls. (C) 
Isokinetic sucrose gradients (10-30%) were performed to analyse mitochondrial RNA 
distribution in uninduced and mtVapC20 cells induced for 3 and 6 days. RNA extracted 
from gradient fractions was analysed by northern blot with different probes, as indicated. 
Cytosolic 28S rRNA and 18S rRNA were used as loading controls. All the northern blot 
data relative to each different time point are representative of one experiment.
Figure 6 – mtDNA levels and transcription in mtVapC20 cells.A
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(A) Relative quantification of mitochondrial DNA levels by qPCR was performed after 10 
days induction. The relative mtDNA content of the induced mtVapC20 line was compared 
to uninduced control (set as equal to 1), normalized to 18S rRNA gene (endogenous 
control). Results are presented as the mean ± S.D. (n = 3). Statistical analysis was 
performed using one sample two-tailed Student’s t test (**, p<0.01). (B) Southern blot 
analysis was performed on total DNA isolated from uninduced (U) and cells induced 
(mtVapC20) for 2, 5 and 10 days. DNA (5 µg) was digested with BamHI, fractionated on 
a 0.7% agarose gel and electroblotted to nylon membrane. The filter was hybridized with 
radiolabeled probe for mitochondrial MTCO2 gene. Total DNA was stained by GelRed® 
(Biotium, Fremont, CA, USA) as loading control. Data for each different time point are 
representative of one experiment. (C) In organello transcription assay was performed on 
uninduced (U) and mtVapC20 cells induced for 6 days. Total RNA was stained by 
SYBRTM Gold (Thermo Fisher Scientific) as loading control, and radiolabel detected as 
previously described. Data are representative of one experiment.
Figure 7 – Effect of mtVapC20 expression on LRPPRC/SLIRP levels, and under 
conditions of mt-SSU depletion.
(A) mtVapC20 was induced for 3, 7 and 10 days. Cell lysates were prepared together 
with uninduced (U) controls. Levels of LRPPRC and SLIRP were determined by 
immunoblotting, SDHA was used as loading control. Data for each different time point are 
representative of one experiment. (B, C) mtVapC20 was expressed for 4 days, 
concomitant with siRNA-mediated depletion of ERAL1 or non-targetting (NT) control 
siRNA treatment. Cell lysates (B) and RNA (C) were prepared. Lysates were separated 
by 12% SDS PAGE and immunodetection revealed steady state levels of the proteins as 
indicated. β-actin was used as loading control. RNA was subjected to northern blotting 
with probes to MTCO1, 16S mt-rRNA and 12S mt-rRNA to indicate changes in steady 
state levels. Probes to cytosolic 28S rRNA were used as loading control. Data obtained 
from both western and northern blots are representative of one experiment. 
Figure 8 – Model depicting mt-mRNA fate in normal and mt-LSU depleted cells. 
Cartoon showing processed and matured mt-mRNAs within RNA granules (A). This 
model proposes that LRPPRC/SLIRP stabilizes mature mt-mRNAs (B) and delivers them A
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to either the mt-SSU or the monosome (C). In this scenario the mt-mRNAs are translated. 
If mt-LSU levels are low, as with mtVapC20 expression (D), mt-mRNAs are still 
transferred to mt-SSU but are degraded due to the lack of protection by the monosome.
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